Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Celltrion Wins Global First Approval For High-Concentration Humira Biosimilar
Yuflyma 100mg/ml Version Of Adalimumab Ready For Launch In Europe
Feb 15 2021
•
By
David Wallace
Celltrion has the first higher-strength adalimumab biosimilar • Source: Shutterstock
More from Biosimilars
More from Products